http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2104033-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86d681fa4179ba38844ea334fe621080 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4031fcf430b243c06b1e848d0705d38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_749e88d30a62c49bea645a252e14ab52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6040acad912abb43362712414cdf547 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 |
filingDate | 1997-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1998-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e1d701768d7cd108ae75be6259cc6ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d728c87b1de33cca136ad276911c8c9 |
publicationDate | 1998-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2104033-C1 |
titleOfInvention | Method of decrease of toxicity of medicinal agents, metals, organic and inorganic compounds and other toxins |
abstract | FIELD: medicine, pharmacotherapy. SUBSTANCE: method involves prescription to patients 1-hydroxygermatran (germatranol, 1-hydroxy-1-germa-2,8,9-trioxa-5-azabicyclo-[3.3.3] -undecane) and its derivatives and/or derivatives of 1-germa-2,8-dioxa-5-azacyclooctane containing hydrogen or organic radicals and/or organoelemental radicals as substituent involving medicinal agent derivatives that were administrated orally, by injections or locally at dose 0.001-01 g/day. EFFECT: enhanced effectiveness of method. 5 cl, 8 tbl, 1 dwg |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2503455-C1 |
priorityDate | 1997-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 289.